1. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China 2. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510000, China. 3. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China 4. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. *These authors contributed equally to this article.
✉ Corresponding authors: Wuguo Deng, Sun Yat-Sen University, Guangzhou, China; Phone/Fax: 86-20-8734-3170; E-mail: degnwgorg.cn; or Lijun Qin, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; E-mail: qinlijunsysu.edu.cn; or Yumin Hu, Sun Yat-Sen University, Guangzhou, China; E-mail: huymorg.cnMore
Published 2025-6-15
Citation:
Tian T, Li J, Li Y, Lu YX, Tang YL, Wang H, Zheng F, Shi D, Long Q, Chen M, Garcia-Manero G, Hu Y, Qin L, Deng W. Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification: Erratum. Theranostics 2025; 15(14):7176-7177. doi:10.7150/thno.118171. https://www.thno.org/v15p7176.htm
The authors regret some incorrect flow cytometry scatter diagrams were accidentally displayed during data organization in Figure 1C, Figure 2F and Figure 3F. The authors confirm that these corrections do not change the result interpretation or conclusions of the article. The authors apologize for any inconvenience that the errors may have caused.
Figure 1
(C) Representative images of cell apoptosis in the indicated cells treated with melatonin for 48 h were determined by Annexin-V/propidium iodide (PI) assay (red numbers indicate subpopulation of cells negative for Annexin V/PI).
Figure 2
(F) Reversion of Melatonin-induced cell death by the antioxidant NAC (N-acetyl-L-cysteine). BaF3/ITD and MV4-11 cells were treated with melatonin (2 mM) alone or a combination NAC (4 mM) for 48 h, then determined by Annexin-V/propidium iodide (PI) assay (red numbers indicate subpopulation of cells negative for Annexin V/PI).
Figure 3
(F) Representative images of cell apoptosis in the indicated cells treated with melatonin, sorafenib or combination for 48 h (red numbers indicate subpopulation of cells negative for Annexin V/PI).
Author contact
Corresponding authors: Wuguo Deng, Sun Yat-Sen University, Guangzhou, China; Phone/Fax: 86-20-8734-3170; E-mail: degnwgorg.cn; or Lijun Qin, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; E-mail: qinlijunsysu.edu.cn; or Yumin Hu, Sun Yat-Sen University, Guangzhou, China; E-mail: huymorg.cn
Citation styles
APA
Tian, T., Li, J., Li, Y., Lu, Y.X., Tang, Y.L., Wang, H., Zheng, F., Shi, D., Long, Q., Chen, M., Garcia-Manero, G., Hu, Y., Qin, L., Deng, W. (2025). Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification: Erratum. Theranostics, 15(14), 7176-7177. https://doi.org/10.7150/thno.118171.
Tian T, Li J, Li Y, Lu YX, Tang YL, Wang H, Zheng F, Shi D, Long Q, Chen M, Garcia-Manero G, Hu Y, Qin L, Deng W. Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification: Erratum. Theranostics 2025; 15(14):7176-7177. doi:10.7150/thno.118171. https://www.thno.org/v15p7176.htm
CSE
Tian T, Li J, Li Y, Lu YX, Tang YL, Wang H, Zheng F, Shi D, Long Q, Chen M, Garcia-Manero G, Hu Y, Qin L, Deng W. 2025. Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification: Erratum. Theranostics. 15(14):7176-7177.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See https://ivyspring.com/terms for full terms and conditions.